9:41
avedro.com
Screenshot of avedro.com
avedro.com favicon

avedro.com

14 technologies
VerifiedVisit$36M014 Tech
Deep Dive

The $218M Stealth Ophthalmology Play

Avedro's Glaukos pivot reveals a high-stakes bet on corneal biology

In the high-stakes world of ophthalmic innovation, Avedro operates as a strategic asset within Glaukos, targeting the $15B+ global glaucoma and corneal disease market. Despite zero public web traffic, this company commands $218.5M in funding—proving that in medtech, clinical data trumps digital presence.

$36.2M
Annual Revenue
$218.5M
Total Funding
0
Monthly Web Visits
N/A
Public SEO Footprint

"When your website gets zero traffic but raises $218M, you're not selling to consumers—you're building for biotech M&A."

The Glaukos Integration Strategy

Avedro isn't a standalone startup—it's a precision asset within Glaukos' ecosystem. The company's $36.2M revenue reflects commercialized therapies for corneal cross-linking, while Glaukos leverages its distribution muscle to scale these treatments globally. This isn't a typical SaaS play; it's a vertical integration move in a capital-intensive medical device sector where clinical validation takes years and regulatory moats are deep.

The Silent Growth Engine

Zero web traffic isn't a bug—it's a feature. Avedro's target audience consists of ophthalmologists, not internet users. Their growth story unfolds in operating rooms and FDA approvals, not Google Analytics dashboards. The $218.5M funding suggests they're building infrastructure for Phase III trials and global commercialization, positioning for a future where corneal diseases become treatable with biologics rather than surgery.

The tech stack reveals a modern but pragmatic approach: jQuery for legacy clinical portals, Tailwind CSS for patient-facing apps, and PWA capabilities for remote monitoring. OneTrust integration signals GDPR/HIPAA compliance is non-negotiable. This isn't a growth-hacking startup—it's a regulated medical entity that happens to use web technologies for compliant patient engagement.

  • Revenue is decoupled from digital footprint—clinical adoption drives growth
  • Funding ($218M) far exceeds revenue ($36M), indicating heavy R&D investment
  • Leadership (VP Clinical Affairs, VP Regulatory) prioritizes compliance over marketing
  • Tech stack suggests hybrid model: B2B clinical tools + B2C patient education
No organic traffic or SEO strategy
Deep clinical moats with FDA-approved therapies
No public product pricing or direct-to-consumer sales
Strategic integration with Glaukos' $1B+ market cap ecosystem
No social proof (Trustpilot reviews, public ratings)
Regulatory expertise (VP Regulatory Affairs) as a competitive barrier

The Anti-Startup Startup

Avedro proves that in biotech, moats are built in labs—not landing pages. For investors, it's a masterclass in capital efficiency: $218M buys clinical validation, not user acquisition. For founders, it's a reminder that some markets are too regulated for growth hacking—and that's exactly where the real value lies.

What tech stack does Avedro use?

18 detected
Video1
Programming Languages1
Privacy & Consent1
Advertising1
Analytics & Marketing1
Performance1
Web Standards2
UI Libraries1
JavaScript Libraries2
Tracking & Analytics4
F
Facebook Pixel
G
Google Analytics
G
Google Tag Manager
G
Google Tag Manager

How much traffic does Avedro get?

Traffic & Engagement

0.0
Pages/Visit
0:00
Avg. Duration
0%
Bounce Rate
Monthly Traffic Trend+0%
0
Oct 2025
Oct
0
Nov 2025
Nov
0
Dec 2025
Dec

How is Avedro's SEO?

Meta Tags

title56 chars

Advancing the Treatment of Ophthalmic Diseases | Glaukos

description153 chars

Glaukos works relentlessly to create and deliver transformative therapies for patients struggling with glaucoma, corneal disorders, and retinal diseases.

languageEN-US

H1 Tags

h1Epioxa is Now FDA Approved
h1Pioneering New Treatments for Chronic Eye Diseases

Schema Types

Unknown

Who works at Avedro?

Loading leads...

What do customers think of Avedro?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Avedro

What is Avedro's Revenue?
Avedro generates approximately $36M in annual revenue. The company has raised $219M in total funding.
What does Avedro do?
Glaukos works relentlessly to create and deliver transformative therapies for patients struggling with glaucoma, corneal disorders, and retinal diseases.
What technologies does Avedro use?
Avedro uses 14 technologies across their website including Video, Programming Languages, CMS. Key technologies include Vimeo, PHP, WordPress.
Who are Avedro's competitors?
Avedro's main competitors include Ironwood Pharmaceuticals, Cubist Pharmaceuticals, Jupiter Life Science Consulting, ONO PHARMA USA, Oncopeptides. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

How to contact Avedro?

What are Avedro's key pages?

Export avedro.com Data

Download the complete tech stack, analytics, leads, and company data for avedro.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About avedro.com

Glaukos works relentlessly to create and deliver transformative therapies for patients struggling with glaucoma, corneal disorders, and retinal diseases.

Company Overview

avedro.com
Website
health
Industry
0
Monthly Visitors
14
Technologies

Contact avedro.com

Technology Stack

avedro.com uses 14 technologies across their website including Vimeo, PHP, WordPress, and more.

Video

Vimeo

Programming Languages

PHP

CMS

WordPress

Privacy & Consent

OneTrust

Advertising

Facebook Pixel

Analytics & Marketing

Google Tag Manager

Traffic & Audience

0
Monthly Visits
0%
Bounce Rate
0.0
Pages/Visit
0:00
Avg. Duration

avedro.com receives approximately 0 monthly visitors. The website has a bounce rate of 0% with visitors viewing an average of 0.0 pages per visit. Users spend an average of 0:00 on the site.

Frequently Asked Questions

What is avedro.com?
Glaukos works relentlessly to create and deliver transformative therapies for patients struggling with glaucoma, corneal disorders, and retinal diseases.
What technologies does avedro.com use?
avedro.com uses 14 technologies including Vimeo, PHP, and 8 more. View the full tech stack analysis above.
How do I contact avedro.com?
You can contact avedro.com through their contact page.
What are avedro.com's social media accounts?
avedro.com is active on twitter, facebook, linkedin, instagram. You can find links to all their social media profiles in the social section above.
Is avedro.com hiring?
Check avedro.com's careers page for current job openings and opportunities.
How popular is avedro.com?
avedro.com receives approximately 0 monthly visitors.

Related Searches

avedro.com pricingavedro.com reviewsavedro.com alternativesavedro.com loginavedro.com careerswhat is avedro.comavedro.com tech stackavedro.com contactavedro.com vs competitorsavedro.com featureshow to use avedro.comavedro.com integrations

This page provides publicly available information about avedro.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit avedro.com directly at https://avedro.com.